KLRA
Kailera Therapeutics, Inc.
NASDAQ Healthcare
18,89 $US
-3.33% today
-27.35% YTD · -27.35% 1Y
10
Insider transactions
SEC Form 4 · AMF · BaFin — rolling 90 days
0 / 200+
Hedge funds tracked
200+ 13F SEC funds, updated quarterly
16
Thematic ETFs
ARK, NANC, GOP, GURU, BUZZ, JEPI, ITA…
24h
Frequency
Daily 5AM UTC pipeline · 2-year historical DB
51
/ 100
MIXED

Kairos Score: 51/100

Composite score aggregating 8 smart money dimensions: insiders (SEC/AMF/BaFin), hedge funds, politicians & gurus, price momentum, valuation, analyst consensus, financial health, earnings momentum. The higher the score, the more favorable the institutional signals consensus.

💡 Detailed breakdown (the 8 sub-scores) available in the Premium dashboard.

About Kailera Therapeutics, Inc.

Kailera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company developing therapies for obesity and related conditions. The company develops clinical- and preclinical-stage therapies, with a product pipeline that includes injectable peptides, oral peptides, and oral small molecules. Key programs include KAI-9531, an injectable GLP-1/GIP receptor dual agonist; KAI-7535, an oral small molecule GLP-1 receptor agonist; and KAI-4729, an injectable GLP-1/GIP/glucagon receptor tri-agonist. Kailera Therapeutics holds exclusive rights...

Key info

👥
Employees
145
💰
Market cap
2 446 959 861,00 $US
🚀
IPO
Apr 17, 2026

🕴️ Insider activity (90 days)

10 transactions — including 0 buys declared by Kailera Therapeutics, Inc. executives to SEC / AMF / BaFin.

RR
Renaud Ronald C JR
CEO & President · 2026-06-09
Other
RI
RTW INVESTMENTS, LP
2026-04-20
Other
RI
RTW INVESTMENTS, LP
2026-04-20
Other

🏦 Hedge Funds

0 institutional funds report a position on KLRA in their latest SEC quarterly filing.

📰 Recent news

13 recent articles on KLRA.

🧠 What makes Kairos Insider

Beyond raw data, we aggregate and score every smart money signal to give you a unique view.

🧠

Kairos Score 0-100

8-dimension composite score: insiders · hedge funds · politicians · momentum · valuation · health · analysts · earnings.

🎯

Insider Clusters

Automatic detection when 3+ executives buy the same stock simultaneously — historically the most reliable signal.

🏦

13F Hedge Funds

Berkshire (Buffett), Pershing Square (Ackman), Tiger Global, Bridgewater + 200 more. Who buys what, each quarter.

📈

ETF Rotations

NANC & GOP (Pelosi & Republicans), GURU (top hedge funds), ARK (Cathie Wood). See who enters and exits each week.

🔥

Google Trends

Spot small caps whose retail interest explodes before the rest of the market. 100+ tickers monitored.

📧

Email alerts

Create your watchlist and receive every morning at 8am the Brief of events on YOUR tickers.

Official sources · Public data · SEC EDGAR — Form 4 & 13F · AMF — Executive filings · BaFin — Directors' Dealings · Yahoo Finance · Alpha Vantage

🔓 Unlock the full analysis

This public page only shows a preview. The full analysis of KLRA on the Kairos Insider dashboard includes:

✅ Full Kairos Score (8-axis radar + synthesis)
✅ History of all 10 insider transactions over 90 days
✅ All 0 hedge funds (among 200+ tracked)
✅ 11 thematic ETFs (ARK, BUZZ, NANC, GOP, JEPI…)
✅ Hot Stocks Google Trends
✅ 2-year history: AUM + rotations
✅ Fundamentals (P/E, PEG, EV/EBITDA, ROE…)
✅ Financial health (Altman Z, Piotroski F)
✅ Sector peers + 6-quarter earnings
See full analysis →
Analyze other tickers for free →

Free signup · Premium €29/month no commitment